ScoreWhy is Anlon Healthcare Ltd ?
1
Strong ability to service debt as the company has a low Debt to EBITDA ratio of 1.81 times
2
Healthy long term growth as Net Sales has grown by an annual rate of 65.60% and Operating profit at 0%
- NET SALES(Q) At Rs 30.98 cr has Fallen at -29.8% (vs previous 4Q average)
- PAT(Q) At Rs 4.80 cr has Fallen at -31.0% (vs previous 4Q average)
3
With ROCE of 17.8, it has a Very Expensive valuation with a 5 Enterprise value to Capital Employed
- Over the past year, while the stock has generated a return of 84.76%, its profits have risen by 36%
4
Despite the size of the company, domestic mutual funds hold only 0% of the company
- Domestic mutual funds have capability to do in-depth on-the-ground research on companies- their small stake may signify either they are not comfortable at the price or the business
5
Market Beating Performance
- Even though the market (BSE500) has generated negative returns of -3.09% in the last 1 year, the stock has been able to generate 84.76% returns
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Anlon Healthcare should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Anlon Healthcare for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Anlon Healthcare
84.68%
1.80
47.41%
Sensex
-9.54%
-0.71
13.49%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
65.60%
EBIT Growth (5y)
58.45%
EBIT to Interest (avg)
9.26
Debt to EBITDA (avg)
2.57
Net Debt to Equity (avg)
0.70
Sales to Capital Employed (avg)
0.86
Tax Ratio
30.12%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
2.89%
ROCE (avg)
9.07%
ROE (avg)
0
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
47
Industry P/E
37
Price to Book Value
5.81
EV to EBIT
27.55
EV to EBITDA
26.62
EV to Capital Employed
5.01
EV to Sales
7.24
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
17.78%
ROE (Latest)
13.85%
Loading Valuation Snapshot...
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bullish
RSI
Bearish
Bollinger Bands
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Dow Theory
Bullish
Bullish
OBV
Bullish
Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend2What is working for the Company
NET SALES(9M)
At Rs 121.98 cr has Grown at 33.18%
-9What is not working for the Company
NET SALES(Q)
At Rs 30.98 cr has Fallen at -29.8% (vs previous 4Q average
PAT(Q)
At Rs 4.80 cr has Fallen at -31.0% (vs previous 4Q average
Loading Valuation Snapshot...
Here's what is not working for Anlon Healthcare
Net Sales - Quarterly
At Rs 30.98 cr has Fallen at -29.8% (vs previous 4Q average)
over average Net Sales of the previous four quarters of Rs 44.13 CrMOJO Watch
Near term sales trend is very negative
Net Sales (Rs Cr)
Profit After Tax (PAT) - Quarterly
At Rs 4.80 cr has Fallen at -31.0% (vs previous 4Q average)
over average PAT of the previous four quarters of Rs 6.95 CrMOJO Watch
Near term PAT trend is very negative
PAT (Rs Cr)
Net Sales - Quarterly
Lowest at Rs 30.98 cr
in the last five quartersMOJO Watch
Near term sales trend is negative
Net Sales (Rs Cr)
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
